US › Healthcare

Aditxt Inc. (ADTX)

US · Healthcare · Biotechnology

$0.000.00%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$12,159

Revenue YoY

+1094.4%

Net profit

$-15.9M

Profit YoY

-179.3%

EPS

$-790.51

Net margin

-131,159.8%

Key statistics

Market cap

$3.0M

Forward P/E

0.4

P/B

0.05

Book value

$-861.43

EPS (TTM)

$-1,380.80

52-week high

$31,364.28

52-week low

$0.00

50-day MA

$0.09

200-day MA

$637.38

Beta

-17.50

Analyst view

Analysts rate Aditxt Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $61.00.

Shareholding

Insiders

0.06%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Danske Bank A/S.	0.00%
Group One Trading, LLC	0.00%
IFP Advisors, LLC	0.00%
Western Wealth Management, LLC	0.00%
UBS Group AG	0.00%
Susquehanna International Group, LLP	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aditxt Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.